Evidence map›Paper›PMID 26917586›Full record

ArticleBrain : a journal of neurology2016

EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.

Susan Byrne, Lara Jansen, Jean-Marie U-King-Im, Ata Siddiqui, Hart G W Lidov, Istvan Bodi, Luke Smith, Rachael Mein, Thomas Cullup, Carlo Dionisi-Vici and 44 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Pancreatic involvement inMolecular genetics and metabolism reports · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Exploiting autophagy and related pathways: pioneering new horizons in cataract therapy.Apoptosis : an international journal on programmed cell death · 2025
    Review
  16. Review
  17. An 18-month-old girl with Vici syndrome: A case report study.Molecular genetics and metabolism reports · 2025
    Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

54 authors at 20 institutions in 15 countries.

Susan Byrne1 Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK.
Lara Jansen2 Department of Basic and Clinical Neuroscience, IoPPN, King's College London, London, UK.
Jean-Marie U-King-Im3 Department of Neuroradiology, Evelina's Children Hospital, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK.
Ata Siddiqui3 Department of Neuroradiology, Evelina's Children Hospital, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK.
Hart G W Lidov4 Department of Pathology, Boston Children's Hospital, Boston MA 02115, USA.
Istvan Bodi5 Department of Clinical Neuropathology, King's College Hospital, London, UK.
Luke Smith6 Randall Division for Cell and Molecular Biophysics, Muscle Signalling Section, King's College, London, UK.
Rachael Mein7 Viapath, Guy's Hospital, London, UK.
Thomas Cullup8 Regional Molecular Genetics Laboratory, Great Ormond Street Hospital, London, UK.
Carlo Dionisi-Vici9 Division of Metabolism, Department of Paediatric Medicine, Bambino Gesù Children's Research Hospital, Rome.
Lihadh Al-Gazali10 Departments of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.
Mohammed Al-Owain11 College of Medicine, Alfaisal University, Riyadh, Saudi Arabia 12 Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Zandre Bruwer13 Genetic and Developmental Medicine Clinic, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.
Khalid Al Thihli13 Genetic and Developmental Medicine Clinic, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.
Rana El-Garhy14 Ain Shams University Hospital, Egypt, Cairo.
Kevin M Flanigan15 Center for Gene Therapy, Nationwide Children's Hospital, Columbus, Ohio, USA.
Kandamurugu Manickam16 Center for Human and Molecular Genetics at The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Erik Zmuda16 Center for Human and Molecular Genetics at The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Wesley Banks16 Center for Human and Molecular Genetics at The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Ruth Gershoni-Baruch17 Institute of Human Genetics, Rambam Health Care Campus and the Technion Faculty of Medicine, Haifa, Israel.
Hanna Mandel18 Metabolic Disease Unit, Meyer Children's Hospital, Rambam Health Care Campus and the Technion Faculty of Medicine, Haifa, Israel.
Efrat Dagan19 Department of Nursing, University of Haifa, Haifa, Israel.
Annick Raas-Rothschild20 Institute of Rare Diseases, Institute of Genetics; Sheba Medical Centre, Tel Hashomer and the Sackler school of Medicine Tel Aviv University Ramat Aviv, Israel.
Hila Barash20 Institute of Rare Diseases, Institute of Genetics; Sheba Medical Centre, Tel Hashomer and the Sackler school of Medicine Tel Aviv University Ramat Aviv, Israel.
Francis Filloux21 Division of Pediatric Neurology, University of Utah School of Medicine and Primary Children's Medical Centre, Salt Lake City, Utah, USA.
Donnell Creel22 University of Utah School of Medicine, Moran Eye Centre, Salt Lake City, Utah, USA.
Michael Harris23 Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington DC, USA.
Ada Hamosh24 McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, USA.
Stefan Kölker25 Division of Child Neurology and Metabolic Medicine, University Children's Hospital, Heidelberg, Germany.
Darius Ebrahimi-Fakhari25 Division of Child Neurology and Metabolic Medicine, University Children's Hospital, Heidelberg, Germany.
Georg F Hoffmann25 Division of Child Neurology and Metabolic Medicine, University Children's Hospital, Heidelberg, Germany.
David Manchester26 Department of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, USA.
Philip J Boyer27 Department of Pathology, East Carolina University, Brody School of Medicine, Brody Medical Sciences Building, Greenville, NC 27834, USA.
Adnan Y Manzur28 Dubowitz Neuromuscular Centre, ICH, London, UK.
Charles Marques Lourenco29 Medical Genetics Unit, School of Medicine of Ribeirao Preto, University of Sao Paulo.
Daniela T Pilz30 Institute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
Arveen Kamath30 Institute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
Prab Prabhakar31 Department of Paediatric Neurology, Great Ormond Street Children's Hospital, London, UK.
Vamshi K Rao32 University of Nebraska Medical Center and Childrens Hospital and Medical Center, Omaha, Nebraska, USA.
R Curtis Rogers33 Greenwood Genetic Center, Greenville, South Carolina, USA.
Monique M Ryan34 Departments of Neurology, Royal Children's Hospital and Paediatrics, University of Melbourne, and Murdoch Childrens Research Institute, Melbourne Australia.
Natasha J Brown35 Victorian Clinical Genetics Services, Murdoch Childrens Research Institute Parkville, Australia 36 Department of Paediatrics, University of Melbourne, Parkville, Australia 37 Department of Clinical Genetics, Austin Health, Australia.
Catriona A McLean38 Department of Anatomical Pathology, Alfred Health, Australia.
Edith Said39 Department of Anatomy and Cell Biology, University of Malta, Msida, Malta 40 Section of Medical Genetics, Mater dei Hospital, Msida, Malta.
Ulrike Schara41 Pediatric Neurology, University Childrens Hospital, University of Duisburg-Essen University of Duisburg-Essen, Essen, Germany.
Anja Stein42 Department of Neonatology, University Childrens Hospital, University of Duisburg-Essen, Essen, Germany.
Caroline Sewry43 Dubowitz Neuromuscular Centre, Institute of Child Health and Great Ormond Street Hospital, 30 Guilford Street, London WC1N 1EH, UK.
Laura Travan44 Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
Frits A Wijburg45 Department of Paediatrics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Martin Zenker46 Institute of Human Genetics, University Hospital Magdeburg, Germany.
Shehla Mohammed47 Department of Clinical Genetics, Guy's Hospital, London, UK.
Manolis Fanto2 Department of Basic and Clinical Neuroscience, IoPPN, King's College London, London, UK.
Mathias Gautel6 Randall Division for Cell and Molecular Biophysics, Muscle Signalling Section, King's College, London, UK.
Heinz Jungbluth1 Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK 6 Randall Division for Cell and Molecular Biophysics, Muscle Signalling Section, King's College, London, UK 48 Department of Basic and Clinical Neuroscience, IoPPN, King's College London, London, UK Heinz.Jungbluth@gstt.nhs.uk.
Guy's and St Thomas' NHS Foundation Trust · GBKing's College London · GBNationwide Children's Hospital · USGuy's Hospital · GBHeidelberg University · DESultan Qaboos University Hospital · OMUniversity College London · GBUniversity Hospital of Wales · GBUniversity of Duisburg-Essen · DEUniversity of Utah · USAin Shams University Hospital · EGAlfred Health · AUBoston Children's Hospital · USChildren's Hospital Colorado · USChildren's Hospital & Medical Center · USChildren's Research Hospital · JPEast Carolina University · USGeorgetown University Medical Center · USGreat Ormond Street Hospital · GBGreenwood Genetic Center · US

Funding

Medical Research Council G0600251Medical Research Council G1002186
6 · The paper itself

Abstract

Vici syndrome is a progressive neurodevelopmental multisystem disorder due to recessive mutations in the key autophagy gene EPG5. We report genetic, clinical, neuroradiological, and neuropathological features of 50 children from 30 families, as well as the neuronal phenotype of EPG5 knock-down in Drosophila melanogaster. We identified 39 different EPG5 mutations, most of them truncating and predicted to result in reduced EPG5 protein. Most mutations were private, but three recurrent mutations (p.Met2242Cysfs*5, p.Arg417*, and p.Gln336Arg) indicated possible founder effects. Presentation was mainly neonatal, with marked hypotonia and feeding difficulties. In addition to the five principal features (callosal agenesis, cataracts, hypopigmentation, cardiomyopathy, and immune dysfunction), we identified three equally consistent features (profound developmental delay, progressive microcephaly, and failure to thrive). The manifestation of all eight of these features has a specificity of 97%, and a sensitivity of 89% for the presence of an EPG5 mutation and will allow informed decisions about genetic testing. Clinical progression was relentless and many children died in infancy. Survival analysis demonstrated a median survival time of 24 months (95% confidence interval 0-49 months), with only a 10th of patients surviving to 5 years of age. Survival outcomes were significantly better in patients with compound heterozygous mutations (P = 0.046), as well as in patients with the recurrent p.Gln336Arg mutation. Acquired microcephaly and regression of skills in long-term survivors suggests a neurodegenerative component superimposed on the principal neurodevelopmental defect. Two-thirds of patients had a severe seizure disorder, placing EPG5 within the rapidly expanding group of genes associated with early-onset epileptic encephalopathies. Consistent neuroradiological features comprised structural abnormalities, in particular callosal agenesis and pontine hypoplasia, delayed myelination and, less frequently, thalamic signal intensity changes evolving over time. Typical muscle biopsy features included fibre size variability, central/internal nuclei, abnormal glycogen storage, presence of autophagic vacuoles and secondary mitochondrial abnormalities. Nerve biopsy performed in one case revealed subtotal absence of myelinated axons. Post-mortem examinations in three patients confirmed neurodevelopmental and neurodegenerative features and multisystem involvement. Finally, downregulation of epg5 (CG14299) in Drosophila resulted in autophagic abnormalities and progressive neurodegeneration. We conclude that EPG5-related Vici syndrome defines a novel group of neurodevelopmental disorders that should be considered in patients with suggestive features in whom mitochondrial, glycogen, or lysosomal storage disorders have been excluded. Neurological progression over time indicates an intriguing link between neurodevelopment and neurodegeneration, also supported by neurodegenerative features in epg5-deficient Drosophila, and recent implication of other autophagy regulators in late-onset neurodegenerative disease.

Indexed as

Agenesis of Corpus CallosumAnimalsAutophagyAutophagy-Related ProteinsCataractChild, PreschoolCross-Sectional StudiesDrosophila melanogasterFemaleHippocampusHumansLysosomal Membrane ProteinsMaleMutationNeurodevelopmental DisordersProteinsAutophagy-Related ProteinsEPG5 protein, humanLysosomal Membrane ProteinsProteinsVesicular Transport Proteinscallosal agenesisectopic P granules autophagy protein 5EPG5neurodegenerationneurodevelopmentVici syndrome

Identifiers

PMID26917586
PMCPMC4766378
OpenAlexW2288653447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.